Airway procedures and hemangiomas: Treatment patterns and outcome in U.S. pediatric hospitals

International Journal of Pediatric Otorhinolaryngology

Volumn 73, Issue 9, 2009, Pages 1302-1307

  Perkins, Jonathan A ^a,b   Oliaei, Sepehr ^a,d   Garrison, Michelle M ^a,b,c   Manning, Scott C ^a,b   Christakis, Dimitri A ^a,b,c  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Database factual; Hemangioma; Mortality; Pediatric; Surgery; Tracheotomy; Treatment outcome

Indexed keywords

AMINOPHYLLINE; ANTACID AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOPHOSPHAMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERFERON; IPRATROPIUM BROMIDE; PROTON PUMP INHIBITOR; STEROID; THEOPHYLLINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; HEMANGIOMA; HOSPITAL READMISSION; HUMAN; INFANT; LARYNX SURGERY; LASER SURGERY; MAJOR CLINICAL STUDY; PEDIATRIC HOSPITAL; PEDIATRIC SURGERY; PRIORITY JOURNAL; RESPIRATORY TRACT TUMOR; TRACHEA SURGERY; TRACHEOTOMY; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HEMANGIOMA; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; LARYNGEAL NEOPLASMS; LASER THERAPY; MALE; PATIENT READMISSION; RETROSPECTIVE STUDIES; TRACHEOTOMY; TREATMENT OUTCOME; UNITED STATES;

EID: 67651164997     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2009.06.005     Document Type: Article

References (21)

1. Drolet B.A., Esterly N.B., and Frieden I.J. Hemangiomas in children. N. Engl. J. Med. 341 3 (1999) 173-181
2. Chiller K.G., Passaro D., and Frieden I.J. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch. Dermatol. 138 12 (2002) 1567-1576
3. Benjamin B., and Carter P. Congenital laryngeal hemangioma. Ann. Otol. Rhinol. Laryngol. 92 5 Pt 1 (1983) 448-455
4. Herman A.R., and Carucci J.A. Management of obstructive airway hemangiomas in the neonate. J. Drugs Dermatol. 1 3 (2002) 331-332
5. Bitar M.A., Moukarbel R.V., and Zalzal G.H. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol. Head Neck Surg. 132 2 (2005) 226-231
6. Berard M., Sordello S., Ortega N., Carrier J.L., Peyri N., Wassef M., et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am. J. Pathol. 150 4 (1997) 1315-1326
7. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., and Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102 8 (2000) 898-901
8. Bielenberg D.R., Bucana C.D., Sanchez R., Mulliken J.B., Folkman J., and Fidler I.J. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int. J. Oncol. 14 3 (1999) 401-408
9. Khan Z.A., Melero-Martin J.M., Wu X., Paruchuri S., Boscolo E., Mulliken J.B., et al. Endothelial progenitor cells from infantile hemangioma and from umbilical cord blood display unique cellular responses to endostatin. Blood 108 3 (2006) 915-921
10. Kontzoglou G., Triaridis S., Noussios G., Valeri R., and Nanas C. Subglottic hemangioma treated with interferon alpha 2A. Acta Otorhinolaryngol. Belg. 56 1 (2002) 83-85
11. Ohlms L.A., Jones D.T., McGill T.J., and Healy G.B. Interferon alfa-2a therapy for airway hemangiomas. Ann. Otol. Rhinol. Laryngol. 103 1 (1994) 1-8
12. Perez J., Pardo J., and Gomez C. Vincristine-an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol. 41 2 (2002) 197-199
13. Vijayasekaran S., White D.R., Hartley B.E., Rutter M.J., Elluru R.G., and Cotton R.T. Open excision of subglottic hemangiomas to avoid tracheostomy. Arch. Otolaryngol. Head Neck Surg. 132 2 (2006) 159-163
14. Chatrath P., Black M., Jani P., Albert D.M., and Bailey C.M. A review of the current management of infantile subglottic haemangioma, including a comparison of CO(2) laser therapy versus tracheostomy. Int. J. Pediatr. Otorhinolaryngol. 64 2 (2002) 143-157
15. Phipps C.D., Gibson W.S., and Wood W.E. Infantile subglottic hemangioma: a review and presentation of two cases of surgical excision. Int. J. Pediatr. Otorhinolaryngol. 41 1 (1997) 71-79
16. Kittle K., Currier K., Dyk L., and Newman K. Using a pediatric database to drive quality improvement. Semin. Pediatr. Surg. 11 1 (2002) 60-63
17. Purvis D.J., Harper J.I., Hartley B.E., and Sebire N.J. Absent/reduced glucose transporter-1 protein expression in infantile subglottic haemangiomas. Br. J. Dermatol. 155 5 (2006) 1041-1044
18. Orlow S.J., Isakoff M.S., and Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J. Pediatr. 131 4 (1997) 643-646
19. Waner M., North P.E., Scherer K.A., Frieden I.J., Waner A., and Mihm Jr. M.C. The nonrandom distribution of facial hemangiomas. Arch. Dermatol. 139 7 (2003) 869-875
20. Seikaly H., and Cuyler J.P. Infantile subglottic hemangioma. J. Otolaryngol. 23 2 (1994) 135-137
21. Wahrman J.E., and Honig P.J. Hemangiomas. Pediatr. Rev. 15 7 (1994) 266-271